Pomerantz Law Firm Urges LifeMD Investors to Act on Class Action Lawsuit

Investor Alert: LifeMD Class Action

Overview

Pomerantz Law Firm has issued a reminder to investors who have incurred losses in LifeMD, Inc. due to the recent class action lawsuit filed against the company. As the case unfolds, affected investors are urged to reach out to the firm to ensure their rights are protected.

What You Need to Know

LifeMD, a public company traded on NASDAQ under the ticker LFMD, is facing serious allegations of engaging in securities fraud and other questionable business practices. Investors holding shares during the Class Period are especially encouraged to step forward, as they may have grounds for becoming a lead plaintiff.

The cutoff date for potential plaintiffs to file their petitions is October 27, 2025. If you purchased or acquired LifeMD securities during the affected time frame, you may wish to investigate your options further. Details for contacting the firm can be found later in this article.

The Triggering Event

On August 5, 2025, LifeMD released its second-quarter financial results. Marc Benathen, the company's Chief Financial Officer, conveyed to shareholders that the business encountered “temporary challenges” that had since been largely resolved. However, he cautioned that the company would need to revise its revenue and EBITDA guidance for the entire year, leading to significant drops in share value. Following the announcement, LifeMD shares plummeted by over 44%, closing at $6.53—a clear red flag for investors.

This sudden decline has triggered the class action lawsuit, highlighting the urgency for affected investors to act. The implications of this case extend beyond mere recovery of losses; it emphasizes the need for accountability and corporate governance in the financial sector.

Pomerantz Law Firm: Commitment to Justice

Headquartered in New York with additional offices in cities like Chicago, Los Angeles, and even internationally in London and Tel Aviv, Pomerantz LLP is well-known for its steadfast focus on corporate law and securities litigation. With more than 85 years of experience, the firm has a substantial history of helping investors who are victims of corporate malpractice, securing multimillion-dollar settlements on their behalf.

Their track record includes pioneering efforts in the field of securities class actions, and they continue to hold companies accountable for fraudulent and unethical practices. Their approach is not only about seeking financial restitution; it is also about protecting the integrity of the market.

How to Get Involved

If you believe you're eligible to be a part of this class action, it is crucial that you act promptly. Here are the steps you should follow:
1. Contact Pomerantz LLP: Reach out to Danielle Peyton at [email protected] or by phone at 646-581-9980. You can also call toll-free at 888-4-POMLAW (Ext. 7980).
2. Provide Necessary Information: Make sure to include your mailing address, phone number, and details regarding the number of LifeMD shares you purchased.
3. Stay Updated: Keep monitoring the situation by checking the firm’s official website for any updates regarding the class action, including changes in deadlines or additional information concerning the case.

Conclusion

The outcome of this class action lawsuit has the potential to impact many LivesMD investors significantly. Pomerantz Law Firm stands ready to fight for justice on behalf of these investors, ensuring that they are not left to bear the financial burden caused by corporate mismanagement and fraud. Time is of the essence; don’t miss your chance to assert your rights in this potentially impactful legal action.

For more details and to review the lawsuit, you can visit Pomerantz Law Firm's website for further information.